Skip to main content
Top
Published in: European Child & Adolescent Psychiatry 2/2014

01-02-2014 | Editorial

Understanding the neuro-developmental pathogenesis of social disability: towards a cross-disorder approach

Author: Catherine Barthélémy

Published in: European Child & Adolescent Psychiatry | Issue 2/2014

Login to get access

Excerpt

Early and persistent impairment in social interaction characterizes autism; it has always defined the condition’s core, from Kanner’s first description up to the latest DSM-5 criteria [1]. …
Literature
1.
go back to reference American Psychiatric Association (2013) Diagnostic and statistical manual of mental disorders, 5th edn. American Psychiatric Association, Washington DC American Psychiatric Association (2013) Diagnostic and statistical manual of mental disorders, 5th edn. American Psychiatric Association, Washington DC
2.
go back to reference Hernandez N, Metzger A, Magné R, Bonnet-Brilhault F, Roux S, Barthélémy C, Martineau J (2009) Exploration of core features of a human face by healthy and autistic adults analyzed by visual scanning. Neuropsychologia 47(4):1004–1012CrossRefPubMed Hernandez N, Metzger A, Magné R, Bonnet-Brilhault F, Roux S, Barthélémy C, Martineau J (2009) Exploration of core features of a human face by healthy and autistic adults analyzed by visual scanning. Neuropsychologia 47(4):1004–1012CrossRefPubMed
3.
go back to reference Dapretto M, Davies MS, Pfeifer JH, Scott AA, Sigman M, Bookheimer SY, Iacoboni M (2006) Understanding emotions in others: mirror neuron dysfunction in children with autism spectrum disorders. Nat Neurosci 9(1):28–30CrossRefPubMedCentralPubMed Dapretto M, Davies MS, Pfeifer JH, Scott AA, Sigman M, Bookheimer SY, Iacoboni M (2006) Understanding emotions in others: mirror neuron dysfunction in children with autism spectrum disorders. Nat Neurosci 9(1):28–30CrossRefPubMedCentralPubMed
4.
go back to reference Gervais H, Belin P, Boddaert N, Leboyer M, Coez A, Sfaello L, Barthélémy C, Brunelle F, Samson Y, Zilbovicius M (2004) Abnormal cortical voice processing in autism. Nat Neurosci 7(8):801–802CrossRefPubMed Gervais H, Belin P, Boddaert N, Leboyer M, Coez A, Sfaello L, Barthélémy C, Brunelle F, Samson Y, Zilbovicius M (2004) Abnormal cortical voice processing in autism. Nat Neurosci 7(8):801–802CrossRefPubMed
5.
go back to reference Cattaneo L, Fabbri-Destro M, Boria S, Pieraccini C, Monti A, Cossu G, Rizzolatti G (2007) Impairment of actions chains in autism and its possible role in intention understanding. Proc Natl Acad Sci USA 104(45):17825–17830CrossRefPubMed Cattaneo L, Fabbri-Destro M, Boria S, Pieraccini C, Monti A, Cossu G, Rizzolatti G (2007) Impairment of actions chains in autism and its possible role in intention understanding. Proc Natl Acad Sci USA 104(45):17825–17830CrossRefPubMed
6.
go back to reference Cossu G, Boria S, Copioli C, Bracceschi R, Giuberti V, Santelli E, Gallese V (2012) Motor representation of actions in children with autism. PLoS One 7(9):e44779CrossRefPubMedCentralPubMed Cossu G, Boria S, Copioli C, Bracceschi R, Giuberti V, Santelli E, Gallese V (2012) Motor representation of actions in children with autism. PLoS One 7(9):e44779CrossRefPubMedCentralPubMed
8.
go back to reference Cholemkery H, Kitzerow J, Rohrmann S, Freitag CM (2014) Validity of the social responsiveness scale to differentiate between autism spectrum disorders and disruptive behaviour disorders. Eur Child Adolesc Psychiatry. doi:10.1007/s00787-013-0427-5 (this issue) Cholemkery H, Kitzerow J, Rohrmann S, Freitag CM (2014) Validity of the social responsiveness scale to differentiate between autism spectrum disorders and disruptive behaviour disorders. Eur Child Adolesc Psychiatry. doi:10.​1007/​s00787-013-0427-5 (this issue)
10.
go back to reference Andari E, Duhamel JR, Zalla T, Herbrecht E, Leboyer M, Sirigu A (2010) Promoting social behaviour with oxytocin in high-functioning autism spectrum disorders. Proc Natl Acad Sci USA 107(9):4389–4394CrossRefPubMed Andari E, Duhamel JR, Zalla T, Herbrecht E, Leboyer M, Sirigu A (2010) Promoting social behaviour with oxytocin in high-functioning autism spectrum disorders. Proc Natl Acad Sci USA 107(9):4389–4394CrossRefPubMed
11.
go back to reference Gordon I, Vander Wyk BC, Bennett RH, Cordeaux C, Lucas MV, Eilbott JA, Zagoory-Sharon O, Leckman JF, Feldman R, Pelphrey KA (2013) Oxytocin enhances brain function in children with autism. Proc Natl Acad Sci USA. doi:10.1073/pnas.1312857110 Gordon I, Vander Wyk BC, Bennett RH, Cordeaux C, Lucas MV, Eilbott JA, Zagoory-Sharon O, Leckman JF, Feldman R, Pelphrey KA (2013) Oxytocin enhances brain function in children with autism. Proc Natl Acad Sci USA. doi:10.​1073/​pnas.​1312857110
12.
go back to reference Adamo N, Huo L, Adelsberg S, Petkova E, Castellanos FX, Di Martino A (2014) Response time intra-subject variability: commonalities between children with autism spectrum disorders and children with ADHD. Eur Child Adolesc Psychiatry. doi:10.1007/s00787-013-0428-4 (this issue) Adamo N, Huo L, Adelsberg S, Petkova E, Castellanos FX, Di Martino A (2014) Response time intra-subject variability: commonalities between children with autism spectrum disorders and children with ADHD. Eur Child Adolesc Psychiatry. doi:10.​1007/​s00787-013-0428-4 (this issue)
13.
go back to reference Van der Meer JM, Oerlemans AM, van Steijn DJ, Lappenschaar MG, de Sonneville LM, Buitelaar JK, Rommelse NN (2012) Are autism spectrum disorder and attention-deficit/hyperactivity disorder different manifestations of one overarching disorder? Cognitive and symptom evidence from a clinical and population-based sample. J Am Acad Child Adolesc Psychiatry 51(11):1160–1172CrossRefPubMed Van der Meer JM, Oerlemans AM, van Steijn DJ, Lappenschaar MG, de Sonneville LM, Buitelaar JK, Rommelse NN (2012) Are autism spectrum disorder and attention-deficit/hyperactivity disorder different manifestations of one overarching disorder? Cognitive and symptom evidence from a clinical and population-based sample. J Am Acad Child Adolesc Psychiatry 51(11):1160–1172CrossRefPubMed
14.
go back to reference Rommelse NN, Franke B, Geurts HM, Hartman CA, Buitelaar JK (2010) Shared heritability of attention-deficit/hyperactivity disorder and autism spectrum disorder. Eur Child Adolesc Psychiatry 19(3):281–295CrossRefPubMedCentralPubMed Rommelse NN, Franke B, Geurts HM, Hartman CA, Buitelaar JK (2010) Shared heritability of attention-deficit/hyperactivity disorder and autism spectrum disorder. Eur Child Adolesc Psychiatry 19(3):281–295CrossRefPubMedCentralPubMed
15.
go back to reference Fatemi SH, Halt AR, Stary JM, Kanodia R, Schulz SC, Realmuto GR (2002) Glutamic acid decarboxylase 65 and 67 kDa proteins are reduced in autistic parietal and cerebellar cortices. Biol Psychiatry 52(8):805–810CrossRefPubMed Fatemi SH, Halt AR, Stary JM, Kanodia R, Schulz SC, Realmuto GR (2002) Glutamic acid decarboxylase 65 and 67 kDa proteins are reduced in autistic parietal and cerebellar cortices. Biol Psychiatry 52(8):805–810CrossRefPubMed
16.
go back to reference Rout UK, Mungan NK, Dhossche DM (2012) Presence of GAD65 autoantibodies in the serum of children with autism or ADHD. Eur Child Adolesc Psychiatry 21(3):141–147CrossRefPubMed Rout UK, Mungan NK, Dhossche DM (2012) Presence of GAD65 autoantibodies in the serum of children with autism or ADHD. Eur Child Adolesc Psychiatry 21(3):141–147CrossRefPubMed
17.
go back to reference Hegvik TA, Husebye ES, Haavik J (2014) Autoantibodies targeting neurotransmitter biosynthetic enzymes in attention-deficit/hyperactivity disorder (ADHD). Eur Child Adolesc Psychiatry. doi:10.1007/s00787-013-0429-3 (this issue) Hegvik TA, Husebye ES, Haavik J (2014) Autoantibodies targeting neurotransmitter biosynthetic enzymes in attention-deficit/hyperactivity disorder (ADHD). Eur Child Adolesc Psychiatry. doi:10.​1007/​s00787-013-0429-3 (this issue)
18.
go back to reference Ben-Ari Y, Khalilov I, Kahle KT, Cherubini E (2012) The GABA excitatory/inhibitory shift in brain maturation and neurological disorders. Neuroscientist 18(5):467–486CrossRefPubMed Ben-Ari Y, Khalilov I, Kahle KT, Cherubini E (2012) The GABA excitatory/inhibitory shift in brain maturation and neurological disorders. Neuroscientist 18(5):467–486CrossRefPubMed
19.
go back to reference Lemonnier E, Degrez C, Phelep M, Tyzio R, Josse F, Grandgeorge M, Hadjikhani N, Ben-Ari Y (2012) A randomised controlled trial of bumetanide in the treatment of autism in children. Transl Psychiatry 11(2):e202. doi:10.1038/tp.2012.124 CrossRef Lemonnier E, Degrez C, Phelep M, Tyzio R, Josse F, Grandgeorge M, Hadjikhani N, Ben-Ari Y (2012) A randomised controlled trial of bumetanide in the treatment of autism in children. Transl Psychiatry 11(2):e202. doi:10.​1038/​tp.​2012.​124 CrossRef
20.
go back to reference Lemonnier E, Robin G, Degrez C, Tyzio R, Grandgeorge M, Ben-Ari Y (2013) Treating fragile X syndrome with the diuretic bumetanide: a case report. Acta Paediatr 102(6):e288–e290CrossRefPubMed Lemonnier E, Robin G, Degrez C, Tyzio R, Grandgeorge M, Ben-Ari Y (2013) Treating fragile X syndrome with the diuretic bumetanide: a case report. Acta Paediatr 102(6):e288–e290CrossRefPubMed
Metadata
Title
Understanding the neuro-developmental pathogenesis of social disability: towards a cross-disorder approach
Author
Catherine Barthélémy
Publication date
01-02-2014
Publisher
Springer Berlin Heidelberg
Published in
European Child & Adolescent Psychiatry / Issue 2/2014
Print ISSN: 1018-8827
Electronic ISSN: 1435-165X
DOI
https://doi.org/10.1007/s00787-013-0516-5

Other articles of this Issue 2/2014

European Child & Adolescent Psychiatry 2/2014 Go to the issue